Atwater Malick’s Encompass Health EHC Stock Holding History

Atwater Malick’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-140	Closed	-$7K	–	88
2019 Q3	$7K	Buy	+140	New	+$7.03K	0.01%	153

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Atwater Malick's EHC Position: Q4 2019 in Review

Atwater Malick sold out of Encompass Health (EHC) in Q4 2019, closing a stake of 140 shares — an estimated $7K sold.

Atwater Malick first reported a position in EHC in Q3 2019 and held it in 1 quarter. The position peaked at $7K in Q3 2019. 397 funds tracked by Wall St. Rank hold EHC as of Q4 2019.

Atwater Malick reported no remaining Encompass Health position as of Q4 2019 after selling out during the quarter.
Atwater Malick sold 140 Encompass Health shares in Q4 2019, an estimated $7K.
Atwater Malick first reported a position in Encompass Health in Q3 2019 and held it in 1 quarter.
Atwater Malick's Encompass Health position peaked at $7K in Q3 2019.
397 funds tracked by Wall St. Rank held Encompass Health as of Q4 2019.

Based on Atwater Malick's 13F filing for Q4 2019, filed 7 Jan 2020.